rs61750595
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000552.5(VWF):c.4975C>T(p.Arg1659Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,612,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000552.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWF | NM_000552.5 | c.4975C>T | p.Arg1659Ter | stop_gained | 28/52 | ENST00000261405.10 | NP_000543.3 | |
VWF | XM_047429501.1 | c.4975C>T | p.Arg1659Ter | stop_gained | 28/52 | XP_047285457.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWF | ENST00000261405.10 | c.4975C>T | p.Arg1659Ter | stop_gained | 28/52 | 1 | NM_000552.5 | ENSP00000261405 | P1 | |
VWF | ENST00000538635.5 | n.421-24509C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000559 AC: 14AN: 250392Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135374
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1460882Hom.: 0 Cov.: 40 AF XY: 0.0000413 AC XY: 30AN XY: 726644
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74314
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Nov 15, 2019 | This nonsense variant causes the premature termination of VWF protein synthesis. In addition, it has been reported in individuals affected with VWD Type 3 in the published literature (PMID: 20147343 (2010), 24712919 (2014), 18485763 (2008), 23834637 (2013), 28971901 (2017), 24675615 (2014)). Therefore, the variant is classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 02, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 35505650, 31050121, 25525159, 1301136, 31589614, 29423401, 23834637, 9845532, 24712919, 18485763, 20147343) - |
not provided, no classification provided | literature only | Academic Unit of Haematology, University of Sheffield | - | - - |
von Willebrand disease type 3 Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico | Nov 01, 2020 | variant already reported in ClinVar - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1992 | - - |
von Willebrand disease type 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1992 | - - |
Hereditary von Willebrand disease Pathogenic:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 19, 2022 | Variant summary: VWF c.4975C>T (p.Arg1659X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 5.6e-05 in 250392 control chromosomes. This frequency does not allow conclusions about variant significance. c.4975C>T has been reported in the literature as a homozygous or compound heterozygous genotype in multiple individuals affected with Von Willebrand Disease type 3 (example, Mohl_2011, Lapi_2022, Zhang_1992, Ahmad_2014). These data indicate that the variant is very likely to be associated with disease. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
VWF-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 17, 2024 | The VWF c.4975C>T variant is predicted to result in premature protein termination (p.Arg1659*). This variant has been well documented to be pathogenic for autosomal recessive Von Willebrand disease 3 (Ahmad et al. 2014. PubMed ID: 24712919; Borràs et al. 2017. PubMed ID: 28971901. Table S4; Gupta et al. 2008. PubMed ID: 18485763). This variant is reported in 0.040% of alleles in individuals of European (Finnish) descent in gnomAD. Nonsense variants in VWF are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at